Reportedly, Bayer thinks about sending Monsanto into chapter 11 to solve litigation|Teva: Moody’s upgrades the rating to Ba1/stable from Ba2/positive|Techem Q2 25 call notes: Likely no imminent call of EUR 750 Temporary Notes|Crédit Logement released its 2024 results|BFCM announces the call for its Perp CMS on 16/06/2025|
Reportedly, Bayer thinks about sending Monsanto into chapter 11 to solve litigation|Teva : Moody’s rehausse le rating de Ba2/positive à Ba1/stable|Techem Q2 25 call notes: Likely no imminent call of EUR 750 Temporary Notes|Crédit Logement a publié ses résultats 2024|BFCM annonce le call de son Perp CMS à la date du 16/06/2025|
COMPAÑÍAS QUE APARECEN EN EL INFORME: ESPAÑA: ACCIONA, ACCIONA ENERGÍA, ENAGÁS. EUROPA: ALLIANZ, DEUTSCHE TELEKOM, SIEMENS. El Ibex sigue imparable Pese a ser una jornada de caídas en la mayoría de las bolsas europeas Italia y España sumaron otra sesión más al alza con el Ibex superando la barrera de los 13.800 puntos. En el STOXX 600 la mayoría de sectores (15/20) cerraron con pérdidas, lideradas por B. de Consumo y Farma frente a Construcción y Bancos que fueron los que más subieron. Por el ...
Four Directors at Anheuser-Busch In Bev SANV sold/sold after exercising options 192,123 shares at between 59.590EUR and 62.826EUR. The significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary tra...
Disclosure of transactions in on shares from May 05th to May 09th, 2025 Nanterre, May 12th, 2025 Disclosure of transactions in on shares from May 05th to May 09th, 2025 Within the framework of the authorization granted by the General Meeting of VINCI SA of April 17th 2025, to trade in its shares and in accordance with the regulations relating to share buybacks, VINCI SA (LEI:213800WFQ334R8UXUG83) declares the purchases of treasury shares below (FR0000125486), carried out from May 05th to May 09th, 2025: I - Aggregate presentation by day and by market Issuer’s n...
Déclaration des transactions sur actions propres Du 05 mai 2025 au 09 mai 2025 Nanterre, le 12 mai 2025 Déclaration des transactions sur actions propres Du 05 mai 2025 au 09 mai 2025 Dans le cadre de l’autorisation consentie par l’Assemblée générale de VINCI SA du 17 avril 2025 pour opérer sur ses actions et conformément à la réglementation relative aux rachats d’action, VINCI SA (LEI: 213800WFQ334R8UXUG83) déclare ci-après les achats d’actions propres (FR0000125486) réalisés du 05 mai 2025 au 09 mai 2025 : I - Présentation agrégée par jour et par marché Nom de l'émetteurJour de la tr...
Moody's Ratings (Moody's) today assigned A3 ratings to the EUR backed senior unsecured notes offered by Anheuser-Busch InBev SA/NV (ABI) in multiple tranches. The proceeds will be used for general corporate purposes including repayment of debt. The ratings of ABI and its subsidiaries including the A...
A director at Vinci sold 10,000 shares at 124.739EUR and the significance rating of the trade was 70/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing ...
Branicks Q1 25 results: Further increase in vacancy; fundamentally not improving|Teva: Q1 2025 results up slightly. Strong momentum in innovative medicines and the new efficiency programme lend credibility to the 2027 guidance.|TPG steps away from Techem acquisition; documentation subject to special call|Banco BPM reports solid Q1 performance|
Branicks Q1 25 results: Further increase in vacancy; fundamentally not improving|Teva : résultats au T1 2025 en légère hausse. La bonne dynamique des médicaments innovants et le nouveau programme d’efficience crédibilisent la guidance 2027.|TPG steps away from Techem acquisition; documentation subject to special call|BPM publie un trimestre record et au-dessus des attentes|
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.